SACT-1

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameSACT-1
Drug Alias NameRilpivirine oral suspensionSACT-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulantsMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptorum Group Llc
China Registration ClassN/A

Develop Information

Active CompaniesAptorum International LtdAptorum Group Llc
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A